Cannabidiol sensitizes triple-negative breast cancer cells to NK cell-mediated killing via EGFR inhibition and FAS upregulation

Abstract Background Triple-negative breast cancer (TNBC) is a highly aggressive subtype lacking targeted therapies, presenting a significant clinical challenge. The epidermal growth factor receptor (EGFR) plays a crucial role in TNBC progression, making it a promising target for therapeutic interven...

Descripció completa

Dades bibliogràfiques

Autors principals:	Perawat Garunyapakun, Boonyanuch Ramwarungkura, Krissada Natungnuy, Chairat Turbpaiboon, Pa-thai Yenchitsomanus, Mutita Junking
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-11-01
Col·lecció:	Journal of Cannabis Research
Matèries:	Cannabidiol Triple-negative breast cancer FAS EGF EGFR
Accés en línia:	https://doi.org/10.1186/s42238-025-00340-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!